Literature DB >> 23609201

Preoperative evaluation of the vertebral arteries and posterior portion of the circle of Willis for cervical spine surgery using 3-dimensional computed tomography angiography.

Atsuki Sano1, Toru Hirano, Kei Watanabe, Tomohiro Izumi, Naoto Endo, Takui Ito, Shoichi Inagawa.   

Abstract

STUDY
DESIGN: A retrospective analysis using prospectively collected data from 3-dimensional computed tomography angiography (3D-CTA).
OBJECTIVE: To investigate the frequency of anomalous vertebral arteries (VA) and variations of the posterior portion of the circle of Willis (PPCW) using 3D-CTA for preventing perioperative iatrogenic vascular complications. SUMMARY OF BACKGROUND DATA: Some studies have reported that preoperative 3D-CTA is useful for determining the VA blood flow in the cervical spine. However, preoperative 3D-CTA has not been used for evaluating PPCW, which functions as vessels collateral to the basilar artery in the case of iatrogenic VA injury.
METHODS: The study included 100 consecutive patients (61 males and 39 females; mean age, 60.4 ± 15.4 yr; range, 11-86 yr) who underwent cervical decompression and/or instrumentation between April 2008 and May 2012. We measured the diameters of the VA (VAD), posterior communicating artery (PCOMD), first segment of the posterior cerebral artery (P1D), and basilar artery (BAD) twice and determined the frequency of anomalous VA and PPCW variations.
RESULTS: Hypoplastic VA, hypoplastic PCOM, and hypoplastic P1 were detected in 11 (11.0%), 81 (81.0%), and 13 patients (13.0%), respectively. Hypoplastic PCOM-P1 and hypoplastic basilar artery were observed in 87 (87.0%) and 3 patients (3.0%), respectively. Overall, 47 patients (47.0%) possessed some degree of abnormal VA blood flow.There were 7 patients (7.0%) with both unilaterally hypoplastic VA and bilaterally hypoplastic PCOM-P1s, in whom iatrogenic VA injury on the dominant side could have caused lethal vascular complications. We termed the hypoplastic VA of the contralateral side without collateral vessels as "critical VA."
CONCLUSION: The VAs and PPCW vary considerably. Preoperative 3D-CTA provides important information for preventing tragic vascular complications caused by iatrogenic VA injury. Taking the risk of radiation into consideration, we recommend this method for patients at the highest risk for iatrogenic VA injury.

Entities:  

Mesh:

Year:  2013        PMID: 23609201     DOI: 10.1097/BRS.0b013e318296e542

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  4 in total

1.  Variations of transverse foramina in cervical vertebrae: what happens to the vertebral artery?

Authors:  Aristeidis Zibis; Vasileios Mitrousias; Nikolaos Galanakis; Nikoletta Chalampalaki; Dimitrios Arvanitis; Apostolos Karantanas
Journal:  Eur Spine J       Date:  2018-02-17       Impact factor: 3.134

2.  Combined CT angiography of the aorta and craniocervical artery: a new imaging protocol for assessment of acute type A aortic dissection.

Authors:  Didi Wen; Hongliang Zhao; Weixun Duan; Rui An; Jian Li; Minwen Zheng
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

3.  Epidemiology and Outcomes of Vertebral Artery Injury in 16 582 Cervical Spine Surgery Patients: An AOSpine North America Multicenter Study.

Authors:  Wellington K Hsu; Abhishek Kannan; Harry T Mai; Michael G Fehlings; Zachary A Smith; Vincent C Traynelis; Ziya L Gokaslan; Alan S Hilibrand; Ahmad Nassr; Paul M Arnold; Thomas E Mroz; Mohamad Bydon; Eric M Massicotte; Wilson Z Ray; Michael P Steinmetz; Gabriel A Smith; Jonathan Pace; Mark Corriveau; Sungho Lee; Robert E Isaacs; Jeffrey C Wang; Elizabeth L Lord; Zorica Buser; K Daniel Riew
Journal:  Global Spine J       Date:  2017-04-01

4.  Radiographic Outcomes of Upper Cervical Fusion for Pediatric Patients Younger Than 10 Years.

Authors:  Kei Watanabe; Toru Hirano; Keiichi Katsumi; Masayuki Ohashi; Hirokazu Shoji; Kazuhiro Hasegawa; Takui Ito; Naoto Endo
Journal:  Spine Surg Relat Res       Date:  2017-12-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.